เอกสารอางอิง
ประยงค ระดมยศ, อัญชลี ตั้งตรงจิตร, พลรัตน วิไลรัตน, ศรชัย หลูอารียสุวรรณ และ แทน จงศุภ
ชัยสิทธิ์. 2544. Atlas of medical parasitology. พิมพครั้งที่ 5. กรุงเทพ: ภาพพิมพ.
วิฑูรย ไวยนันท และ พีรพรรณ ตันอารีย. 2540. ปรสิตวิทยาทางการแพทย. คณะวิทยาศาสตร
มหาวิทยาลัยมหิดล.
Adler, R.R., Ng, AK. and Rote, N.S. 1995. Monoclonal antiphosphatidylserine antibody
inhibits intercellular fusion of the choriocarcinoma line, JAR. Biol Reprod. 53(4): 905-910.
Allaire, A.D., Ballenger K.A., Wells S.R., McMahon M.J. and Lessey, B.A. 2000.
Placental apoptosis in preeclampsia. Obstet Gynecol. 96(2): 271-276.
Anonymous a. Chloroquine diphosphate salt. (Online) Available: http://www.sigma
aldrich.com/structureimages/s/66/c6628.gif.Accessed[September 30, 2004]
Anonymous b. Quinine hemisulfate salt. (Online)
/structureimages/s/12/q1250.gif.Accessed[September 30, 2004]
images/a/36/361593.gif. Accessed [September 30, 2004]
tureimages/s/77/p7771.gif Accessed [September 30, 2004]
Anonymous e. MTT. (Online) Available: http://www.roche-applied-science.com/pack-
insert/1465007a.pdf Accessed [September 30, 2004]
Anonymous f. LDH. (Online) Available: http://www.roche-applied-science.com/pack-
insert/1644793a.pdf Accessed [September 30, 2004]
Aoki, Y., Adachi, S., Yoshiya, N., Honma, S., Kanazawa, K. and Tanaka, K. 1991. Effects
of various growth factors on the proliferation and the differentiation oftrophoblastic cells in vitro. Nippon Sanka Fujinka Gakkai Zasshi. 43(11): 1527-1532.
Aplin, J.D., Lacey, H., Haigh, T., Jones, C.J., Chen, C.P. and Westwood, M. 2000.
Growth factor-extracellular matrix synergy in the control of trophoblastinvasion. Biochem Soc Trans. 28(2): 199-202.
Artavanis-Tsakonas, K. and Riley, E.M. 2002. Innate immune response to malaria: rapid
induction of IFN-from human NK cells by live Plasmodiumfalciparum-infectederythrocytes. J Immunol. 169(6): 2956–2963.
Aschkenazi, S., Straszewski, S., Verwer, K.M.A., Foellmer, H., Rutherford, T. and Mor, G.
2002. Differential regulation and function of the Fas/Fas ligand system inhuman trophoblast cells. Biol Reprod. 66(6): 1853–1861.
Aubouy, A., Bakary, M., Keundjian, A., Mbomat, B., Makita, JR., Migot-Nabias, F., Cot,
M., LeBras, J. and Deloron, P. 2003. Combination of drug level measurementand parasite genotyping data for improved assessment of amodiaquine andsulfadoxine-pyrimethamine efficacies in treating Plasmodium falciparummalaria in Gabonese children. Antimicrob Agents Chemother. 47(1): 231-237.
Beeson, J.G., Amin, N., Kanjala, M. and Rogerson, S.J. 2002. Selective accumulation of
mature asexual stages of Plasmodium falciparum - infected erythrocytes in theplacenta. Infect immun. 70(10): 5412–5415.
Beeson, J.G. and Brown, G.V. 2004. Plasmodium falciparum–infected erythrocytes
demonstrate dual specificity for adhesion to hyaluronic acid and chondroitinsulfate A and have distinct adhesive properties. J Infect Dis. 189(2): 169-179.
Beeson, J.G., Rogerson, S.J., Cooke, B.M., Reeder, J.C., Chai, W., Lawson, A.M.,
Molyneux, M.E. and Brown, G.V. 2000. Adhesion of Plasmodium falciparum -infected erythrocytes to hyaluronic acid in placental malaria. Nat Med. 6(1):86-90.
Beier, J.C. 1998. Malaria parasite development in mosquitoes. Annu. Rev. Entomol. 43:
Bentin-Ley, U., Horn, T., Sjögren, A., Sørensen, S., Larsen, J.F. and Hamberger, L. 2000.
Ultrastructure of human blastocyst–endometrial interactions in vitro. J ReprodFertil. 120(2): 337–350.
Berman, J. 2004. Toxicity of commonly-used antimalarial drugs. J Tmaid. 2(3-4): 171–
Bischof, P. and Finger, I.I. 2005. The human cytotrophoblastic cell, a mononuclear
chameleon. Int J Biochem cell B. 37(1): 1–16.
Black, S., Kadyrov, M., Kaufmann, P., Ugele, B., Emans, N. and Huppertz, B. 2004.
Syncytial fusion of human trophoblast depends on caspase 8. Cell DeathDiffer. 11(1): 90–98.
Bosman, A., Delacollette, C., Olumese, P., Ridley, R.G., Rietveld, A., Shretta, R. and
Teklehaimanot, A. 2000. The use of antimalarial drugs. Geneva, Switzerland,Nov: 50-54.
Bouyou-Akotet, M.K., Kombila, M., Kremsner, P.G., Mavoungou, E. 2004. Cytokine
profiles in peripheral, placental and cord blood in pregnant women from anarea endemic for Plasmodium falciparum. Eur Cytokine Netw. 15(2): 120-125.
Boya, P., Gonzalez-Polo, R.A., Poncet, D., Andreau, K., Vieira, H.L., Roumier, T.,
Perfettini, J.L. and Kroemer, G. 2003. Mitochondrial membranepermeabilization is a critical step of lysosome-initiated apoptosis induced byhydroxychloroquine. Oncogene. 22(25): 3927-3936.
Brabin, B. 1991. An assessment of low birthweight risk in primiparae as an indicator of
malaria control in pregnancy. Int J Epidemiol. 20(1): 276-283.
Brabin, B.J., Romagosa, C., Abdelgalil, S., Menendez, C., Verhoeff, F.H., McGready, R.,
Fletcher, K.A., Owens, S., Dalessandro, U., Nosten, F., Fischer, P.R. and Ordi,J. 2004. The sick placenta the role of malaria. Placenta. 25(5): 359–378.
Catisti, R. and Vercesi, A.E. 1999. Permeability transition pore closure promoted by
quinine. J Bioenerg Biomembr. 31(2): 153-157. Chakraborty, C., Gleeson, L.M., McKinnon, T. and Lala, P.K. 2002. Regulationof human trophoblast migration and invasiveness. Can J Physiol Pharmacol. 80(2): 116-124.
Chandramohan, D., Jaffar, S. and Greenwood, B. 2002. Use of clinical algorithms for
diagnosing malaria. Trop Med Int Health. 7(1): 45-52.
Chaouat, G., Zourbas, S., Ostojic, S., Lappree-Delage, G., Dubanchet ,S., Ledee, N.
and Martal, J. 2002. A brief review of recent data on some cytokineexpressions at the materno-foetal interface which might challenge the classicalTh1/Th2 dichotomy. J Reprod Immunol. 53(1-2): 241–256.
Chen, H.H., Zhou, H.J. and Fang, X. 2003. Inhibition of human cancer cell line growth
and human umbilical vein endothelial cell angiogenesis by artemisininderivatives in vitro. Pharmacol Res. 48(3): 231-236.
Chen, Q., Schlichtherle, M. and Wahlgren, M. 2000. Molecular aspects of severe
malaria. Clin Microbiol Rev. 13(3): 439– 450.
Cheung, A.N.Y. 2003. Pathology of gestational trophoblastic diseases. Best Pract Res
Clin Obstet Gynaecol. 17(6): 849–868.
Chotivanich, K., Udomsangpetch, R., Simpson, J.A., Newton, P., Pukrittayakamee, S.,
Looareesuwan, S. and White, N.J. 2000. Parasite multiplication potential andthe severity of falciparum malaria. J Infect Dis. 181(3): 1206-1209.
Das, C., Kumar, V.S., Gupta, S. and Kumar, S. 2002. Network of cytokines, integrins and
hormones in human trophoblast cells. J Reprod Immunol. 53(1-2): 257–268.
Day, N.P.J., Hien, T.T., Schollaardt, T., Loc, P.P., Chuong, L.V., Chau, T.T.H., Mai,
N.T.H., Phu, N.H., Sinh, D.X., White, N.J. and Ho, M. 1999. The prognostic andpathophysiologic role of pro- and anti-inflammatory cytokines in severemalaria. J Infect Dis. 180(4): 1288–1297.
Dorman, E. and Shulman, C. 2000. Malaria in pregnancy. Curr Obstet Gynaecol. 10:
Duffy, P.E. and Fried, M. 2003. Antibodies that inhibit Plasmodium falciparum adhesion
to chondroitin sulfate A are associated with increased birth weight and thegestational age of newborns. Infect Immun. 71(11): 6620–6623.
Efferth, T. and Oesch, F. 2004. Oxidative stress response of tumor cells: microarray-
based comparison between artemisinins and anthracyclines. BiochemPharmacol. 68(1): 3–10.
Ekvall, H. 2003. Malaria and anemia. Curr Opin Hematol. 10(2): 108-114.
Fievet, N., Moussa, M., Tami, G., Maubert, B., Cot, M., Deloron, P. and Chaouat, G.
2001. Plasmodium falciparum induces a Th1/Th2 disequilibrium, favoring theTh1-Type pathway, in the human placenta. J Infect Dis. 183(10): 1530–1534.
Foley, M. and Tilley, L. 1998. Quinoline Antimalarials: Mechanisms of action and
resistance and prospects for new agents. Pharmacol Ther. 79(1): 55–87.
Frendo, J.L., Vidaud, M., Guibourdenche, J., Luton, D., Muller, F., Bellet, D.,
Giovagrandi, Y., Tarrade, A., Porquet, D., Blot, P. and Evain-Brion, D. 2000. Defect of villous cytotrophoblast differentiation into syncytiotrophoblast inDown’s syndrome. J Clin Endocr Metab. 85(10): 3700-3707.
Fried, M. and Duffy, P.E. 1998. Maternal malaria and parasite adhesion. J Mol Med. 76
Fried, M., Muga, R.O., Misore, A.O. and Duffy, P.E. 1998. Malaria elicits type 1 cytokines
in the human placenta:IFN-g and TNF-a associated with pregnancy outcomes. J Immunol. 160(5): 2523–2530.
Fritsche, G., Larcher, C., Schennach, H. and Weiss, G. 2001. Regulatory interactions
between iron and nitric oxide metabolism for immune defense againstPlasmodium falciparum infection. J Infect Dis. 183(9): 1388–1394.
Garcia-Lloret, M.I., Yui J., Winkler-Lowen B., Guilbert, L.J. 1996. Epidermal growth factor
inhibits cytokine-induced apoptosis of primary human trophoblasts. J CellPhysiol. 167(2): 324-332.
Gaur, D., Mayer, D.C.G. and Miller, L.H. 2004. Parasite ligand-host receptor interactions
during invasion of erythrocytes by plasmodium merozoites. Int J Parasitol. 34(13-14): 1413-1429.
Gay, F., Traore, B., Zanoni, J., Danis, M. and Fribourg-Blanc, A. 1996. Direct acridine
orange fluorescence examination of blood slides compared to currenttechniques for malaria diagnosis. Trans R Soc Trop Med Hyg. 90(5): 516- 518.
Gerami-Naiai, B., Dovzhenko, O.V., Durning, M., Wegner, F.H., Thomson, J.A. and
Golos, T.G. 2004. Trophoblast differentiation in embryoid bodies derived fromhuman embryonic stem cells. Endocrinology. 145(4): 1517–1524.
Ginsburg, H., Ward, S.A. and Bray, P.G. 1999. An integrated model of chloroquine
action. Parasitol Today.15(9): 357-360.
Glazier, J.D. and Jansson, T. 2004. Placental transport in early pregnancy—a workshop
Good, M.F. and Doolan, D.L. 1999. Immune effector mechanisms in malaria. Curr Opin
Gottifredi, V. and Prives, C. 2005. The S phase checkpoint: When the crowd meets at
the fork. Semin Cell Dev Biol. 16(3): 355–368.
Gude, N.M., Roberts, C.T., Kalionis, B. and King,R.G. 2004. Growth and function of the
normal human placenta. Thromb Res. 114(5-6): 397-407.
Halpaap, B., Ndjave, M., Paris, M., Benakis, A and Kremsner, P.G.1998. Plasma levels of
artesunate and dihydroartemisinin in children with Plasmodium falciparummalaria in Gabon after administration of 50-milligram artesunate suppositories. Am J Trop Med Hyg. 58(3): 365-368.
Hanscheid, T. 1999. Diagnosis of malaria: a review of alternatives to conventional
microscopy. Clin Lab Haematol. 21(4): 235-245.
Heddini, A. 2002. Malaria pathogenesis: a jigsaw with an increasing number of pieces.
Int J Parasitol. 32(13): 1587–1598.
Hensmann, M. and Kwiatkowski, D. 2001. Cellular basis of early cytokine response to
Plasmodium falciparum. Infect Immun. 69(4): 2364–2371.
Hill, J.A., Polgar, K. and Anderson, D.J. 1995. T-helper 1-type immunity to trophoblast in
women with recurrent spontaneous abortion. JAMA. 273(24): 1933-1936.
Hisaeda, H., Yasutomo, K. and Himeno, K. 2005. Malaria: immune evasion by parasites.
Int J Biochem Cell B. 37: 700–706.
Holmgren, L., Claesson-Welsh, L., Heldin, C.H. and Ohlsson, R. 1992. The expression of
PDGF alpha- and beta-receptors in subpopulations of PDGF-producing cells
implicates autocrine stimulatory loops in the control of proliferation incytotrophoblasts that have invaded the maternal endometrium. GrowthFactors. 6(3): 219-31.
Holst, F.G.E., Hemmer, C.J., Foth, C., Seitz, R., Egbring, R. and Dietrich, M. 1999. Low
levels of fibrin-stabilizing factor (FACTOR XIII) in human: Plasmodiumfalciparum malaria correlation with clinical serverity. Am J Trop Med Hyg. 60(1): 99–104.
Jason, J., Archibald, L.K., Nwanyanwu, O.C., Bell, M., Buchanan, I., Larned, J.,
Kazembe, P.N., Dobbie, H., Parekh, B., Byrd, M.G., Eick, A., Han, A. andJARvis, W.R. 2001. Cytokines and malaria parasitemia. Clin Immunol. 100(2):208–218.
Jerzak, M. and Bischof, P. 2002. Apoptosis in the first trimester human placenta: the role
in maintaining immune privilege at the maternal–foetal interface and in thetrophoblast remodeling. Eur J Obstet Gynecol Repord Biol. 100(2): 138–142.
Jones, S.M. and Kazlauskas, A. 2001. Growth factor-dependent signaling and cell cycle
progression. Febs Lett. 490(3): 110-116.
Kingdom, J., Huppertz, B., Seaward, G. and Kaufmann, P. 2000. Development of the
placental villous tree and its consequences for fetal growth. Eur J ObstetGynecol Reprod Biol. 92(1): 35-43.
Knofler, M., Mosl, B., Bauer, S., Griesinger, G. and Husslein, P. 2000. TNF-α/TNFRI in
primary and immortalized first trimester cytotrophoblasts. Placenta. 21(5-6):525–535.
Kwak, J.Y., Beaman, K.D., Gilman-Sachs, A., Ruiz, J.E., Schewitz, D. and Beer, A.E.
1995. Up-regulated expression of CD56+, CD56+/CD16+, and CD19+ cells inperipheral blood lymphocytes in pregnant women with recurrent pregnancylosses. Am J Reprod Immunol. 34(2): 93-99.
Lacroix, M.C., Guibourdenche, J., Frendo, J.L., Muller, F. and Evain-Brion, D. 2002.
Human placental growth hormone--a review. Placenta. 23: 87-94.
Leke, R.G., Djokam, R.R., Mbu, R., Leke, R.J., Fogako, J., Megnekou, R., Metenou, S.,
Sama, G., Zhou, Y., Cadigan, T., Parra, M. and Taylor, D.W. 1999. Detection ofthe Plasmodium falciparum antigen histidine-rich protein 2 in blood ofpregnant women: implications for diagnosing placental malaria. J ClinMicrobiol. 37(9): 2992–2996.
Leopardi, O., Naughten, W., Salvia, L., Colecchia, M., Matteelli, A., Zucchi, A., Shein, A.,
Muchi, J.A., Carosi, G. and Ghione, M. 1996. Malaric placentas. A quantitativestudy and clinico-pathological correlations. Pathol Res Pract. 192(9): 899-900.
Leung, D.N., Smith, S.C., To, K.F., Sahota, D.S. and Baker, P.N. 2001. Increased
placental apoptosis in pregnancies complicated by preeclampsia. Am JObstet Gynecol. 184(6): 1249-1250.
Leung, H.W.C., Wu, C.H., Lin, C.H. and Lee, H.Z. 2005. Luteolin induced DNA damage
leading to human lung squamous carcinoma CH27 cell apoptosis. Eur JPharmacol. 508(1-3): 77– 83
Li, R. and Zhuang, L. 1997. The effects of growth factors on human normal placental
cytotrophoblast cell proliferation. Hum Reprod. 12(4): 830–834.
Lone, F.W., Qureshi, R.N. and Emanuel, F. 2004. Maternal anaemia and its impact on
perinatal outcome. Trop Med Int Health. 9(4): 486–490.
Louis, H.M., Dror I. B., Kevin M. and Ogobara K. D. 2002. The pathogenic basis of
Luder, C.G.K., Gross, U. and Lopes, M.F. 2001. Intracellular protozoan parasites and
apoptosis: diverse strategies to modulate parasite–host interactions. TrendsParasitol. 17(10): 480-486.
Lyke, K.E., Diallo, D.A., Dicko, A., Kone, A., Coulibaly, D., Guindo, A., Cissoko, Y.,
Sangare, L., Coulibaly, S., Dakouo, B., Taylor, T.E., Doumbo, O.K. and Plowe,C.V. 2003. Association of intraleukocytic Plasmodium falciparum malariapigment with disease severity, clinical manifestations, and prognosis in severemalaria. Am J Trop Med Hyg69(3): 253–259.
Mackintosh, C.L., Beeson, J.G. and Marsh, K. 2004. Clinical features and pathogenesis
of severe malaria. Trends Parasitol. 20(12): 597-603.
Maeda, H. and Shiraishi, A. 1996. TGF-beta contributes to the shift toward Th2-type
responses through direct and IL-10-mediated pathways in tumor-bearing mice. J Immunol. 156(1): 73-78.
Malaguarnera, L, and Musumeci, S. 2002. The immune response to Plasmodiumfalciparum malaria. Lancet Infect Dis. 2(8): 472-478.
Matteelli, A., Caligaris, S., Castelli, F. and Carosi, G. 1997. The placenta and malaria.
Ann Trop Med Parasitol. 91(7): 803-810.
Mayxay, M., Pukrittayakamee, S., Chotivanich, K., Looareesuwan, S. and White, N.J.
2001. Persistence of Plasmodium falciparum HRP-2 in successfully treatedacute falciparum malaria. Trans R Soc Trop Med Hyg. 95(2): 179-182.
McGready, R., Ashley, E.A. and Nosten, F. 2004. Malaria and the pregnant traveller. J
McGready, R., Cho,T.,Keo, N.K., Thwai,K.L., Villegas, L., Looareesuwan, S., White, N.J.
and Nosten, F. 2001. Artemisinin antimalarials in pregnancy: a prospectivetreatment study of 539 episodes of multidrug-resistant Plasmodium falciparum. Clin Infect Dis. 33(12): 2009–2016.
McGready, R. and Nosten, F. 1999. The Thai-Burmese border : drug studies of
Plasmodium falciparum in pregnancy. Ann Trop Med Parasitol. 93: 19-23.
McGready, R., Thwai, K.L., Cho, T., Looareesuwan, S., White, N.J. and Nosten, F. 2002.
The effects of quinine and chloroquine antimalarial treatments in the firsttrimester of pregnancy. Trans R Soc Trop Med Hyg. 96(2): 180-184.
Meshnick, S.R. 2002. Artemisinin mechanisms of action, resistance and toxicity. Int J
Miller, L.H., Baruch, D.I., Marsh, K. and Doumbo, O.K. 2002. The pathogenic basis of
malaria. Nature. 415(6872): 673-679.
Moody, A. 2002. Rapid Diagnostic Tests for Malaria Parasites. Clin Microbiol Rev. 15(1):
Moormann, A.M., Sullivan, A.D., Rochford, R.A., Chensue, S.W., Bock, P.J., Nyirenda, T.
and Meshnick, S.R. 1999. Malaria and pregnancy: placental cytokineexpression and its relationship to intrauterine growth retardation. J Infect Dis. 180(6): 1987–1993.
Mota, M.M., Giordano, S. and Rodriguez, A. 2004. Targeting plasmodium host cells:
survival within hepatocytes. Trends Mol Med. 10(10): 487-492.
Mota, M.M. and Rodriguez, A. 2002. Invasion of mammalian host cells by plasmodium
sporozoites. Bioessays. 24(2): 149-156.
Murray, C.K., Bell, D., Gasser, R.A. and Wongsrichanalai, C. 2003. Rapid diagnostic
testing for malaria. Trop Med Int Health. 8(10): 876–883.
Newman, R.D., Parise, M.E., Slutsker, L., Nahlen, B. and Steketee, R.W. 2003. Safety,
efficacy and determinants of effectiveness of antimalarial drugs duringpregnancy: implications for prevention programmes in Plasmodiumfalciparum-endemic sub-Saharan Africa. Trop Med Int Health. 8(6): 488–506.
Newton, C.R.J.C., Hien, T.T., White, N. 2000. Cerebral malaria. J Neurol Neurosurg
Ngan, H.Y.S. 2003. Gestational trophoblastic disease. Curr Obstet Gynaecol. 13: 95-
Nosten, F., Kuile, F.T., Maelankirri, L., Decludt, B. and White, N.J. 1991. Malaria during
pregnancy in an area of unstable endemicity. Trans R Soc Trop Med Hyg. 85(4): 424-429.
Nosten, F., McGready, R., Simpson, J.A., Thwai, K.L., Balkan, S., Cho, T., HkiriJARoen,
L., Looareesuwan, S. and White, N.J. 1999. Effects of Plasmodium vivaxmalaria in pregnancy. Lancet. 354(9178): 546–549.
Nosten, F., Rogerson, S.J., Beeson, J.G., McGready, R., Mutabingwa, T.K. and Brabin,
B. 2004. Malaria in pregnancy and the endemicity spectrum what can welearn?. Trends Parasitol. 20(9): 425-432.
Ocana-Morgner, C., Mota, M.M. and Rodriguez, A. 2003. Malaria blood stage
suppression of liver stage immunity by dendritic cells. J Exp Med. 197(2): 143–151.
Oh, M.D., Shin, H., Shin, D., Kim, U., Lee, S., Kim, N., Chol, M.H., Chai, J.Y. and Choe,
K. 2001. Clinical features of vivax malaria. Am J Trop Med Hyg. 65(2): 143–146.
Okoko, B.J., Enwere, G. and Ota, M.O.C. 2003. The epidemiology and consequences of
maternal malaria a review of immunological basis. Acta Trop. 87(2): 193-205.
Olliaro, P. 2001. Mode of action and mechanisms of resistance for antimalarial drugs.
Olliaro, P.L., Haynes, R.K., Meunier, B. and Yuthavong, Y. 2001. Possible modes of
action of the artemisinin type compounds. Trends Parasitol. 17(3): 122-126.
Omer, F.M., Kurtzhals, J.A. and Riley, E.M. 2000. Maintaining the immunological balance
in parasitic infections: a role for TGF-beta. Parasitol Today. 16(1): 18-23.
Omonuwa, S. and Omonuwa, S. 2002. Malaria recurrence caused by Plasmodiumfalciparum. J Am Board Fam Pract. 15(2): 159-160.
Pain, A., Ferguson, D.J.P., Kai, O., Urban, B.C., Lowe, B., Marsh, K. and Roberts, D.J.
2001. Platelet-mediated clumping of Plasmodium falciparum-infectederythrocytes is a common adhesive phenotype and is associated with severemalaria. PNAS. 98(4): 1805–1810.
Perry J.E., Grossmann M.E. and Tindall D.J. 1998. Epidermal growth factor induces
cyclin D1 in a human prostate cancer cell line. Prostate. 35(2): 117-124.
Phillips, R.S. 2001. Current status of malaria and potential for control. Clin Microbiol Rev
Pichyangkul, S., Saengkrai, P., Webster, H.K. 1994. Plasmodium falciparum pigment
induces monocytes to release high levels of tumor necrosis factor-alpha andinterleukin-1 beta. Am J Trop Med Hyg. 51(4): 430-435.
Playford, E.G. and Walker, J. 2002. Evaluation of the ICT malaria P.f/P.v and the optiMal
rapid diagnostic tests for malaria in febrile returned travellers. J Clin Microbiol. 40(11): 4166–4171.
Plebanski, M. and Hill, A.V.S. 2000. The immunology of malaria infection. Curr Opin
Poch, B., Gansauge, F., Schwarz, A., Seufferlein, T., Schnelldorfer, T., Ramadani, M.,
Beger, H.G. and Gansauge, S. 2001. Epidermal growth factor induces cyclinD1 in human pancreatic carcinoma: evidence for a cyclin D1-dependent cellcycle progression. Pancreas. 23(3): 280-287.
Pukrittayakamee, S., Wanwimolruk, S., Stepniewska, K., Jantra, A., Huyakorn, S.,
Looareesuwan, S. and White, N.J. 2003. Quinine pharmacokinetic-pharmacodynamic relationships in uncomplicated falciparum malaria. Antimicrob Agents Chemother: 47(11): 3458–3463.
Qari, S.H., Shi, Y.P., Goldman, I.F., Nahlen, B.L., Tibayrenc, M. and Lal, A.A. 1998.
Predicted and observed alleles of Plasmodium falciparum merozoite surfaceprotein-1 (MSP-1), a potential malaria vaccine antigen. Mol Biochem Parasitol. 92(2): 241-252.
Rhee, M.S.M., Akanmori, B.D., Waterfall, M. and Riley, E.M. 2001. Changes in cytokine
production associated with acquired immunity to Plasmodium falciparummalaria. Clin Exp Immunol. 126(3): 503-510.
Ridley, R.G. 2002. Medical need, scientific opportunity and the drive for antimalarial
Roberts, C.W., Satoskar, A. and Alexander, J. 1996. Sex steroids, pregnancy-associated
hormones and immunity t o parasitic infection. Parasitol Today. 12(10): 382-388.
Rogerson, S.J. 2003. Sequestration: causes and consequences. Redox Rep. 8(5): 295-
Rogerson, S.J. and Beeson, J.G. 1999. The placenta in malaria: mechanisms of
infection, disease and foetal morbidity. Ann Trop Med Parasitol. 93: 35-42.
Saito, S. 2001. Cytokine cross-talk between mother and the embryo/placenta. J Reprod
Scholl, P.F., Kongkasuriyachai, D., Demirev, P.A., Feldman, A.B., Lin, J.S., Sullivan, D.J.
and Kumar, N. 2004. Rapid detection of malaria infection in vivo by laserdesorption mass spectrometry. Am J Trop Med Hyg. 71(5): 546-551.
Shams, M. and Ahmed, A. 1994. Localization of mRNA for basic fibroblast growth factor
in human placenta. Growth Factors. 11(2): 105-111.
Simon, C., Moreno, C., Remohy, J. and Pellicer, A. 1998. Cytokines and embryo
implantation. J Reprod Immunol. 39(1-2): 117–131.
Smith, N.C. 1996. An immunological hypothesis to explain the enhanced susceptibility to
malaria during pregnancy. Parasitol today. 12(1): 4-6.
Smith, J.D., Chitnis, C.E., Craig, A.G., Roberts, D.J., Hudson-Taylor, D.E., Peterson, D.S.,
Pinches, R., Newbold, C.I. and Miller, L.H. 1995. Switches in expression ofPlasmodium falciparum var genes correlate with changes in antigenic andcytoadherent phenotypes of infected erythrocytes. Cell. 82(1): 101-110.
Smith, S., Francisa, R., Guilbert, L. and Baker, P.N. 2002. Growth factor rescue of
cytokine mediated trophoblast apoptosis. Placenta. 23(4): 322–330.
Sprecher, H., Barr, H.M., Slotky, J.I., Tzukerman, M., Eytan, G.D. and Assaraf, Y.G.
1995. Alteration of mitochondrial gene expression and disruption ofrespiratory function by the lipophilic antifolate pyrimethamine in mammaliancells. J Biol Chem. 270(35): 20668-20676.
Staalsoe, T., Megnekou, R., Fievet, N., Ricke, C.H., Zornig, H.D., Leke, R., Taylor, D.W.,
Deloron, P. and Hviid, L. 2001. Acquisition and decay of antibodies topregnancy-associated variant antigens on the surface of Plasmodiumfalciparum–infected erythrocytes that protect against placental parasitemia. JInfect Dis. 184(5): 618–626.
Steketee, R.W., Wirima, J.J., Hightower, A.W., Slutsker, L., Heymann, D.L. and Breman,
J.G. 1996. The effect of malaria and malaria prevention in pregnancy on
offspring birthweight, prematurity, and intrauterine growth retardation in ruralMalawi. Am J Trop Med Hyg. 55: 33-41.
Stoute, J.A., Odindo, A.O., Owuor, B.O., Mibei, E.K., Opollo, M.O. and Waitumbi, J.N.
2003. Loss of red blood cell–complement regulatory proteins and increasedlevels of circulating immune complexes are associated with severe malarialanemia. J Infect Dis. 187(3): 522-528.
Su, Z. and Stevenson, M.M. 2000. Central role of endogenous gamma interferon in
protective immunity against blood-stage Plasmodium chabaudi AS infection. Infect Immun. 68(8): 4399–4406.
Suguitan, A.L., Leke, R.G.F., Fouda, G., Zhou, A., Thuita, L., Metenou, S., Fogako, J.,
Megnekou, R. and Taylor, D.W. 2003. Changes in the levels of chemokinesand cytokines in the placentas of women with Plasmodiumfalciparum malaria. J Infect Dis. 188(7): 1074-1082.
Suh, K.N., Kain, K.C. and Keystone, J.S. 2004. Malaria. CMAJ. 170 (11): 1693-1702. Sullivan, D.J. 2002. Theories on malarial pigment formation and quinoline Action. Int J
Talman, A.M., Domarle, O., Mckenzie, F.E., Ariey, F. and Robert, V. 2004.
Gametocytogenesis: the puberty of plasmodium falciparum. Malaria J. 3(1):24.
Testa, J., Traore, LK., Nabalma, S., Sondo, B. and Guissou, I.P. 1998. Chloroquine
resistance of Plasmodium falciparum. study of a surveillance method based onplacental apposition and determination of blood chloroquine in pregnantwomen. Sante. 8(4): 293-296.
Thellin, O. and Heinen, E. 2003. Pregnancy and the immune system between tolerance
and rejection. Toxicology. 185(3): 179-184.
Torre, D., Speranza, F., Giola, M., Matteelli, A., Tambini, R. and Biondi, G. 2002. Role of
Th1 and Th2 cytokines in immune response to uncomplicated Plasmodiumfalciparum malaria. Clin Diagn Lab Immun. 9(2): 348–351.
Tsuji, M. and Zavala, F. 2003. T cells as mediators of protective immunity against liver
stages of plasmodium. Trends Parasitol. 19(2): 88-93.
Urban, B.C., Ferguson, D.J., Pain, A., Willcox, N., Plebanski, M., Austyn, J.M. and
Roberts, D.J. 1999. Plasmodium falciparum-infected erythrocytes modulate thematuration of dendritic cells. Nature. 400(6739): 73-77.
Urban, B.C., Willcox, N. and Roberts, D.J. 2001. A role for CD36 in the regulation of
dendritic cell function. PNAS. 98(15): 8750–8755.
Wahl, S.M. 1994. Transforming Growth Factor/3: The good, the bad, and the ugly. J Exp
Wickramasinghe, .S.N. and Abdalla, S.H. 2000. Blood and bone marrow changes in
malaria. Baillieres Best Pract Res Clin Haematol. 13(2): 277-299.
Winston, J.T. and Pledger, W.J. 1993. Growth factor regulation of cyclin D1 mRNA
expression through protein synthesis-dependent and -independentmechanisms. Mol Biol Cell. 4(11): 1133-1144.
Wongchotigul, V., Suwanna, N., Krudsood, S., Chindanond, D., Kano, S., Hanaoka, N.,
Akai, Y., Maekawa, Y., Nakayama, S., Kojima, S. and Looareesuwan, S. 2004. The use of flow cytometry as a diagnostic test for malaria parasites. SoutheastAsian J Trop Med Public Health. 35(3): 552-559.
World Health Organization. 2005. Malaria control today. Geneva, Switzerland, March: 1-
Yang, Y.Z., Little, B. and Meshnick, S.R. 1994. Alkylation of proteins by artemisinin.
Effects of heme, pH, and drug structure. Biochem Pharmacol. 48(3): 569-573.
Yui, J., Garcia-Lloret, M., Wegmann, T.G. and Guilbert, L.J. 1994. Cytotoxicity of tumour
necrosis factor-alpha and gamma-interferon against primary human placentaltrophoblasts. Placenta. 15(8): 819-835.
Zhang, C., Gong, Y., Ma, H., An, C. and Chen, D. 2001. Reactive oxygen species
involved in trichosanthin-induced apoptosis of human choriocarcinoma cells. Biochem. J. 355(3): 653-661.
Application and experience of CAN as a low cost OBDH bus system MAPLD 2004, Washington D.C. USA, 8th – 10th September, 2004 Surrey Satel ite Technology Ltd, University of Surrey, Guildford, GU2 7XH, UK. Abstract This paper gives an overview of Surrey Satel ite Technology Ltd. (SSTL) use of CAN bus on its recent missions. It gives a description of the SSTL CAN topology and goes i
Synthesis and Antibacterial Activities of Aza Tetracyclines: A Novel Class of Tetracycline Analogs Contact: X. XIAO, R. CLARK, M. HE, D. LOFLAND, W. O’BRIEN, L. PLAMONDON Leland Webster Tetraphase Pharmaceuticals, Watertown, MA. Leland.webster@tphase.com Abstract/Introduction Results Results Background: A unique fully synthetic platform for tetracycline synt